Skip to main content

Regenerative Therapy Using Blood-Derived Stem Cells

  • Book
  • © 2012

Overview

  • Provides an up-to-date review of the various types of blood-derived cells with regenerative capacity and identifies opportunities for intervention by examining specific clinical applications
  • Discusses the concept of using umbilical cord blood
  • Covers technical and conceptual issues such as ex vivo expansion and the generation of induced pluripotent stem cells

Part of the book series: Stem Cell Biology and Regenerative Medicine (STEMCELL)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (15 chapters)

Keywords

About this book

Blood has long been viewed as a conduit for therapy, stemming from the ancient days of phlebotomy to remove evil humors to the development of successful blood transfusions to replace missing blood components. The identification and characterization of hematopoietic stem cells by Drs. Till and McCulloch  revolutionized the field and soon after, non-hematopoietic stem and progenitor cells were characterized from the blood and bone marrow. Some of these cell types and various blood-derived cell lineages are involved in the repair of various types of tissue damage that span the spectrum of medical disorders. The goal of this book is to provide an up-to-date review of the various types of blood-derived cells with regenerative capacity, identify opportunities for intervention by examining specific clinical applications, and recognize the regulatory environment that will encompass future therapies in regenerative medicine.

Editors and Affiliations

  • Ottawa Hospital Research Institute, Ottawa, Canada

    David S. Allan

  • , Center for Medical Research (ZMF), Medical University of Graz, Graz, Austria

    Dirk Strunk

About the editors

Dr. David S. Allan is a clinician scientist at the Ottawa Hospital Research Institute, affiliated with the Blood & Marrow Transplant Program at the University of Ottawa. His research interests focus of fundamental aspects of vascular progenitor biology and on translational studies in the repair of organ toxicity in patients undergoing hematopoietic stem cell transplantation.

 

Dr. Dirk Strunk is a clinician scientist with the Hematopoietic Stem Cell Transplantation Program and Head of Stem Cell Research at the Medical University of Graz in Austria. His research team develops novel transplantation strategies using mesenchymal stromal cells and endothelial progenitors and has developed animal protein-free methods of cell expansion that facilitate translational studies in humans.

Bibliographic Information

  • Book Title: Regenerative Therapy Using Blood-Derived Stem Cells

  • Editors: David S. Allan, Dirk Strunk

  • Series Title: Stem Cell Biology and Regenerative Medicine

  • DOI: https://doi.org/10.1007/978-1-61779-471-1

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: Springer Science+Business Media, LLC 2012

  • Hardcover ISBN: 978-1-61779-470-4Published: 15 November 2011

  • Softcover ISBN: 978-1-62703-885-0Published: 25 January 2014

  • eBook ISBN: 978-1-61779-471-1Published: 16 November 2011

  • Series ISSN: 2196-8985

  • Series E-ISSN: 2196-8993

  • Edition Number: 1

  • Number of Pages: XII, 220

  • Topics: Stem Cells, Cell Biology, Hematology

Publish with us